Role of hepatitis C virus in dual and triple hepatitis virus infection.
about
The influence of hepatitis B virus on antiviral treatment with interferon and ribavirin in Asian patients with hepatitis C virus/hepatitis B virus coinfection: a meta-analysisNatural history and treatment of hepatitis B virus and hepatitis C virus coinfectionKASL clinical practice guidelines: management of chronic hepatitis BSOCS1 and SOCS3 are targeted by hepatitis C virus core/gC1qR ligation to inhibit T-cell functionAcute hepatitis C virus (HCV) infection in chronic carriers of hepatitis B virus (HBV): the impact of underlying active HBV replication on persistence of HCV infection and antibody responses to HCVLack of evidence for hepatitis G virus replication in the livers of patients coinfected with hepatitis C and G virusesHigh incidence of hepatitis C virus infection in hemodialysis patients in units with high prevalenceMolecular mechanisms underlying occult hepatitis B virus infection.A comparative review of HLA associations with hepatitis B and C viral infections across global populationsPersonalized Therapy of Chronic Hepatitis C and B Dually Infected Patients With Pegylated Interferon Plus Ribavirin: A Randomized StudyDirect binding of hepatitis C virus core to gC1qR on CD4+ and CD8+ T cells leads to impaired activation of Lck and Akt.An overview of triple infection with hepatitis B, C and D viruses.New animal models of hepatitis B and C.Hepatitis B virus and hepatitis C virus dual infection.Inhibition of the HCV core protein on the immune response to HBV surface antigen and on HBV gene expression and replication in vivo.A novel multiplex real-time PCR assay for the concurrent detection of hepatitis A, B and C viruses in patients with acute hepatitis.Hepatitis B virus (HBV) and hepatitis C virus (HCV) dual infection.Current Concepts of HBV/HCV Coinfection: Coexistence, but Not Necessarily in Harmony.Occult hepatitis B virus infection and its clinical implications.Occult and Overt HBV Co-Infections Independently Predict Postoperative Prognosis in HCV-Associated Hepatocellular Carcinoma.Replication of genome wide association studies on hepatocellular carcinoma susceptibility loci in a Chinese population.Hepatitis flares and hepatitis B e antigen seroconversion: implication in anti-hepatitis B virus therapy.Mutations in TP53 and CTNNB1 in Relation to Hepatitis B and C Infections in Hepatocellular Carcinomas from ThailandTreatment of hepatitis B in decompensated liver cirrhosis.Reduced antibody reactivity to hepatitis C virus antigens in hemodialysis patients coinfected with hepatitis B virus.The natural course of hepatitis C virus infection 18 years after an epidemic outbreak of non-A, non-B hepatitis in a plasmapheresis centre.Seroprevalence of the Hepatitis B, Hepatitis C, and Human Immunodeficiency Viruses and Treponema pallidum at the Beijing General Hospital from 2010 to 2014: A Cross-Sectional Study.Clinical features and treatment efficacy of peginterferon alfa plus ribavirin in chronic hepatitis C patients coinfected with hepatitis B virusAsian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update.HCV co-infection and markers of liver injury and fibrosis among HIV-positive childbearing women in Ukraine: results from a cohort study.Spontaneous viral clearance after 6-21 years of hepatitis B and C viruses coinfection in high HBV endemic area.Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and CHepatitis B virus/hepatitis C virus coinfection: epidemiology, clinical features, viral interactions and treatment.Clinical outcomes of delayed clearance of serum HBsAG in patients with chronic HBV infection.Current therapy for hepatitis C or D or immunodeficiency virus concurrent infection with chronic hepatitis B.MicroRNA-122 as a predictor of HBsAg seroclearance in hepatitis B and C dual infected patients treated with interferon and ribavirinSuccessful treatment of HCV/HBV/HDV-coinfection with pegylated interferon and ribavirinCausal Mediation Analysis of Survival Outcome with Multiple Mediators.Histopathology and pathobiology of hepatotropic virus-induced liver injury.Current therapeutic trends in therapy for chronic viral hepatitis.
P2860
Q21245094-A9422A97-9933-406E-9692-61B07510F3B9Q24815355-62C00EB2-B7F7-4B87-90BE-15C61AE42233Q26752475-CE920CAC-2F3E-4FF9-9654-F8A62A002354Q27472767-1C18AF87-BE06-44C1-9CE6-7C4D6AB082A1Q27477956-AFF52155-C5B8-4CE2-B29B-D353F017EC70Q27480882-FD5A18FF-70E4-4AF1-8C58-8F038A0A7B5FQ27485700-8FAECA52-AE40-4583-A134-14373238B282Q27686923-DDB9A21C-7B52-4712-92D2-5FC6DDC09876Q28299722-ACF13037-610A-4BEC-8AA3-E8AD16C19ACDQ28608449-455967AB-C9F9-4F7B-851A-5007228B1BEEQ30433630-EFAABC42-081C-48DC-AD75-B67A2C2E844AQ30485092-F69820A3-A2C9-48E4-995C-8F3B66691772Q34282823-9539E118-455B-4A55-9081-3EF559ADFA05Q34404975-F9790200-F5ED-4A21-A275-AA6E48EA393FQ34425267-1658A010-1C25-4D0A-A86D-F06B49FAF12EQ34474056-02A577AC-A8DD-4672-9E97-68E5E0030368Q34485074-46E206E2-953B-49BF-A229-FCE569B0D058Q34502980-86C05DE7-9FCF-4E2E-98FB-886FE8592D68Q34703532-84D33B83-6E2B-4EC0-9153-043E8359492CQ34785204-3843806A-C591-4C42-A91D-B8E99CA1EB18Q35035182-6E805058-B870-4C66-BDFD-D19AAA2934D7Q35072187-B64CD08F-B112-439A-9275-1AD9AC8C2061Q35094277-FD138631-574D-4632-87EE-BABD1CCDF662Q35207784-E1A65C4B-FCFB-4662-9C94-665DE3B1863CQ35231658-7A7A5EE5-FBB7-449D-8B10-1775D2BB610AQ35354705-A7036738-A035-4D77-80C7-C0C9D5CC1F3EQ35821446-8E4AA878-4571-422D-BA5C-B30E048EC033Q35833159-3C0F6D6F-8BC6-4773-8276-5EFBB9D2144BQ36135493-3B926120-92FA-4A29-8CC5-FF11B9A00EF5Q36220953-4A931A24-461A-4608-810C-649029BD6496Q36309219-D327512D-A43D-43FE-8926-E4DE9967C651Q36920164-07F3E916-60B6-444A-8319-94370A422530Q37132382-DF140FE6-1CCA-4A31-BFD0-EB331EFB1272Q37205209-EBBBAB08-8A60-417C-B756-9438A01B4067Q37278249-ACB276B5-9AA9-447C-8A20-1DF62C332FD2Q37281927-15BB59BC-D744-4FE1-9E91-06AFFFEF1224Q38679899-6C0BB08F-40FB-4856-948E-D8C3406C484AQ40291207-96BFD97F-6B48-4C03-9520-08BA27574F52Q41667261-69EA4C86-9118-4763-831A-09CEFD5724A3Q41667359-D0C47D9D-AB4B-4168-8252-30C00CEDF2DE
P2860
Role of hepatitis C virus in dual and triple hepatitis virus infection.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Role of hepatitis C virus in dual and triple hepatitis virus infection.
@en
type
label
Role of hepatitis C virus in dual and triple hepatitis virus infection.
@en
prefLabel
Role of hepatitis C virus in dual and triple hepatitis virus infection.
@en
P1433
P1476
Role of hepatitis C virus in dual and triple hepatitis virus infection.
@en
P304
P356
10.1016/0270-9139(95)90615-0
P407
P433
P50
P577
1995-10-01T00:00:00Z